| Financial Year |
March 31 2023 |
| Monetary Funds |
576,645,847.95 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
427,500.00 |
| Accounts Receivable |
152,833,779.29 |
| Advances to Suppliers |
31,784,606.74 |
| Other Receivables |
871,160.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
282,780,731.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,586,780.95 |
| Total Current Assets |
1,179,985,364.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
904,433,795.58 |
| Under-construction Projects |
92,212,207.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,191,335.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
65,031.51 |
| Deferred Income Tax Assets |
7,824,433.21 |
| Other Non-Current Assets |
64,719,207.95 |
| Sub-Total of Non-Current Assets |
1,180,446,011.26 |
| Total Assets |
2,360,431,376.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,892,527.08 |
| Accounts Payable |
115,461,988.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,978,904.38 |
| Taxes Payable |
14,408,862.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,266.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
600,000.00 |
| Other Current Liabilities |
1,766,801.25 |
| Sub-Total of Current Liabilities |
171,216,069.71 |
| Long-term Loans |
-- |
| Bonds Payable |
498,622,073.60 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,322,782.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
524,640,417.79 |
| Total Liabilities |
695,856,487.50 |
| Paid-In Capital(Or Share Stock) |
326,398,400.00 |
| Capital Surplus |
577,446,288.61 |
| Surplus Reserve |
50,911,046.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
624,770,949.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,664,574,888.55 |
| Owner's Equity（Stockholder's Equity） |
1,664,574,888.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,360,431,376.05 |
